Frontlight ResearchEarly access
Trial site
Gastrointestinal Associates of Northeast Tennessee
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Liver cirrhosis1 trial
- Primary biliary cholangitis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Status
- Completed2 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Gilead Sciences1 trial
- Hoffmann-La Roche1 trial
- Intercept Pharmaceuticals1 trial
- Ipsen1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026